1000Farmacie raised an additional $10 million in its Series A funding round, totaling $25 million, to enhance its prescription delivery service targeting chronic patients.

Target Information

1000Farmacie has successfully completed the second tranche of its Series A funding round, raising an additional $10 million to bring the total funding to $25 million. The round saw participation from notable investors, including the Club degli Investitori, GG 1978, P101 with its P102 and ITA 500 funds, Azimut, HBM Healthcare Investments, LIFTT, IAG, Healthware Ventures, and Feel Venture. With a current active customer base exceeding 500,000 and annualized sales of over $50 million, 1000Farmacie positions itself as a key player in the online pharmacy market.

The company is strategically focusing on the prescription (RX) market, particularly prioritizing the launch of an innovative home delivery service tailored for chronic patients. This service aims to enhance patient accessibility to medications, thereby improving adherence and overall healthcare outcomes.

Industry Overview in Italy

The pharmaceutical industry in Italy is witnessing significant growth, propelled by the increasing demand for health services and a rising aging population. The market is c